News

ReNeuron's latest press releases

ReNeuron presents key pre-clinical efficacy data with ReN009 stem cell therapy at leading UK diabetes conference. 03/03/10

Guildford, UK, 3 March 2010: ReNeuron Group plc (LSE: RENE.L) today announces further positive pre-clinical efficacy data with its ReN009 stem cell …

ReNeuron announces fundraising. 22/02/10

Guildford, UK, 22 February 2010: ReNeuron Group plc (LSE: RENE.L) today announces that it has raised approximately £4.7 million, before expenses,…

ReNeuron and Schepens Eye Research Institute receive unrestricted industrial grant to support US retinal stem cell collaboration . 19/02/10

Guildford, UK, 18 February 2010: ReNeuron Group plc (LSE: RENE.L) today announces that its ongoing US collaboration with the Schepens Eye Research …

ReNeuron receives final regulatory approval to commence landmark stroke clinical trial in UK. 10/02/10

Guildford, UK, 10 February 2010: ReNeuron Group plc (LSE: RENE.L) today announces that the UK Gene Therapy Advisory Committee (GTAC) has given a full …

Clinical Advisory Board appointments. 01/02/10

Guildford, UK, 1 February 2010: ReNeuron Group plc (LSE: RENE.L) today announces the appointment of four opinion-leading clinicians to its newly-…

Regulatory Update. 28/01/10

Guildford, UK, 28 January 2010: ReNeuron Group plc (LSE: RENE.L) today provides a regulatory update regarding its ReN001 stem cell therapy for stroke.…

Office of Life Sciences. 27/01/10

Guildford, UK, 27 January 2010: ReNeuron Group plc (LSE: RENE.L) welcomes yesterday’s launch of the “Life Sciences 2010: Delivering the …

Regulatory Update. 11/01/10

Guildford, UK, 11 January 2010: ReNeuron Group plc (LSE: RENE.L) today provides a regulatory update regarding its ReN001 stem cell therapy for stroke …

1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  >> 

If you would like to be alerted when a new press release is added, please click here to register with our Alerting Service.

Top of pageTop of page